Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia Inc. demonstrated a strong financial performance with total revenue per Accountable Healthcare System Client (AHSC) increasing by 5.6% year-over-year to $26,622, driven by client expansion across its diverse solution offerings. Additionally, patient payment volumes grew to $1.181 billion in Q3 2026, reflecting a robust 9.3% year-over-year increase, which underscores the company's success in both attracting new clients and expanding existing relationships. Furthermore, the upward revision of adjusted EBITDA guidance to a range of $99 million to $101 million, representing 172% year-over-year growth and exceeding consensus estimates, solidifies a positive outlook for the company amid strengthening healthcare utilization trends.

Bears say

Phreesia's financial performance indicates areas of concern, notably with a sequential decline in the take rate from 2.8% to 2.7%, which can adversely affect revenue streams despite stable payment facilitator volumes. While operating expenses decreased year-over-year, the overall revenue for 3Q26 of $120.3 million fell slightly short of expectations, raising concerns about the company's growth trajectory. Additionally, the slight shortfall in client numbers compared to consensus expectations and potential risks associated with another COVID-19 surge could further hinder the company's topline growth in a challenging healthcare environment.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $31.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $31.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.